Skip to main content

Table 2 Demographic and clinical characteristics of 24 ADPKD patients

From: Non-contrast low-dose CT can be used for volumetry of ADPKD

n = 24

Standard dose

Low dose

Age, yr, median (IQR)

47.1 (32.0, 78.5)

Male, n (%)

11 (45.8%)

eGFR Cr-Cys, mL/min/1.73m2 (IQR)

86.7 (35.1, 114.1)

Cr, mg/dL, median (IQR)

1.0 (0.8, 1.7)

Cystatin C, mg/dL, median (IQR)

0.9 (0.7, 2.2)

Volume by stereology, mL, median (IQR)

1492 (738, 2012)

1485 (714, 1948)

Absolute difference (standard – low) of volume, mL, median (IQR)

22.6 (0.66, 81.81)

% Difference ((standard – low)/standard) of volume, mL, median (IQR)

2.67(-0.60, 4.21)

Coefficient of variation, mL, median (IQR)

0.02(0.01, 0.03)

ICC

0.998

Volume by ellipsoid, mL, median (IQR)

1436 (687, 2195)

1364 (670, 1861)

DLP, mGy·cm, median (IQR)

219 (185, 265)

48 (37, 66)

  1. Abbreviations: ADPKD, autosomal dominant polycystic kidney disease; IQR, interquartile range; eGFR, estimated glomerular filtration rate; Cr, creatinine; DLP, dose-length product